|
Dr. Teichman is an independent consultant in the area of strategic drug discovery and development. He has worked on over 40 medical products in various stages of development from the earliest identification of leads in research to supporting commercial-stage products. Most recently Dr. Teichman served as Vice President and Chief Development Officer at ARYx Therapeutics where he was responsible for identifying and advancing three products from the research stage into clinical development.
During the past 20 years Dr. Teichman has held senior level executive positions at Genentech Medco Research (now part of King Pharmaceuticals) Glycomed (now part of Ligand Pharmaceuticals) and Mimetix. He has provided scientific advisory services and has acted in an interim executive role for numerous early-stage and established biotechnology companies.
Dr. Teichman holds an M.D. from Columbia University and a B.S. in Chemistry from Columbia College Columbia University. He is board certified in Internal Medicine and Cardiology. Dr. Teichman is a Fellow of the American College of Cardiology (FACC) and the American College of Physicians (FACP). Dr. Teichman served as Associate Clinical Professor of Medicine at University of California in San Francisco from 1990 to 2001. He has more than 40 original publications reviews and abstracts published in peer-reviewed and invited medical journals. | 